23andMe files for bankruptcy to sell itself (reuters.com)

Article summary

23andMe has filed for bankruptcy, which may allow the company to be sold as a whole entity rather than being broken apart and its assets sold piecemeal. The bankruptcy filing is under Chapter 11, which enables the company to restructure its debt and negotiate with creditors. This move has raised concerns among customers about the potential sale of their genetic data. The company's data handling practices, including soft deletion, have also been questioned.

Main themes

• Bankruptcy and restructuring
• Data privacy and security
• Corporate debt and finance
• Genetic data ownership
• Data deletion practices

What commenters say

• The Chapter 11 bankruptcy filing allows 23andMe to restructure its debt and potentially sell the company as a whole, rather than being broken apart.
• Soft deletion practices can be misleading and may not actually remove customer data, posing a risk to data privacy and security.
• Some argue that soft deletion is necessary for business and regulatory reasons, while others believe it is a flawed practice that prioritizes company interests over customer privacy.
• Customers have a right to expect their data to be truly deleted when they request it, and companies should prioritize transparency and clarity in their data handling practices.
• The sale of 23andMe's genetic data in the event of a bankruptcy sale raises concerns about the ownership and control of sensitive personal information.
• Companies should educate customers about data deletion practices and provide clear warnings about the consequences of deleting their data, but some argue that customers often ignore such warnings.
• The use of soft deletion can be seen as a trade-off between data retention and customer privacy, with some arguing that it is a necessary compromise and others seeing it as a flawed approach.